Drug Distributor Advisory Committee

PURPOSE: This rule establishes operating guidelines for the drug distributor advisory committee. (1) As authorized in section 338.140.4., RSMo, an advisory committee, composed of five (5) members, one (1) of whom shall be a representative of pharmacy, but who shall not be a member of the pharmacy board, three (3) of whom shall be representatives of wholesale drug distributors, as defined in section 338.330, RSMo, and one (1) of whom shall be a representative of drug manufacturers, shall be appointed by the State Board of Pharmacy. (2) Appointments to the advisory committee shall be made by the president of the board. (A) Except for the initial committee appointments, each appointment shall be for a term of five (5) years. Beginning with the first committee appointments, the terms will be staggered so that one (1) term will expire each year after that. (B) No appointment shall become effective until approved by the board. Each candidate shall meet with the board prior to any decision by the board to confirm. This meeting will be held in order for the board to review the candidate’s credentials and to familiarize him/her with board personnel and advisory committee responsibilities. (C) Terms of new committee members shall commence on July 1, unless the appointment is to fill an unexpired term. (3) The advisory committee shall organize by the election of a chairman and vice-chairman who shall hold their offices for one (1) year and until their successors shall have been elected and qualified. A majority of the committee shall constitute a quorum for the transaction of business. (4) The advisory committee shall review and make any recommendations to the board on the merit of all rules dealing with pharmacy distributors, wholesale drug distributors and drug manufacturers which are proposed by the board. (A) The advisory committee shall maintain minutes of all meetings held. (B) Any recommendations made by the advisory committee concerning proposed regulations shall be noted and explained in the minutes which will be provided to the board at an open session meeting of the board. The advisory committee may provide other documentation, reports or correspondence to the board when necessary. (C) Any official recommendations to be made from the committee to the board must be initiated by a motion that receives a majority vote in favor by the committee. This motion and vote shall be recorded in the minutes. (D) The board will review any recommendations made by the advisory committee and will provide a response to the committee if any action is taken or modifications are made to a proposed regulation. In addition, the board shall note in the Missouri Register the dates and a summary of any recommendations made by the advisory committee on a proposed rule and report any responses that are made to those recommendations from the board. (5) Committee members shall be reimbursed or all reasonable and necessary expenses for attending committee meetings. However, only expenses incurred within Missouri will routinely be reimbursed. No request for the compensation of expenses provided in this rule shall be processed for payment unless sufficient funds are available for that purpose within the appropriation of the State Board of Pharmacy. AUTHORITY: section 338.390, RSMo Supp. 1989.* This rule originally filed as 4 CSR 220-5.010. Original rule filed Jan. 3, 1990, effective April 26, 1990. Moved to 20 CSR 2220-5.010, effective Aug. 28, 2006. *Original authority: 338.390, RSMo 1989.